Gynecology & Obstetrics
Open Access

Abstract

Hydronephrosis Complicating Endometriosis in a Case of Infiltrating Lobular Carcinoma of the Breast Treated with Tamoxifen

Peter Graham and Najmun Nahar

Uterine endometrialpolyp, hyperplasia and malignant transformation are well known side effects of Tamoxifen use in breast cancer patients. We present a case of hydronephrosis secondary to extra-uterine endometriosis in a female with mixed Invasive Ductal Carcinoma (IDC) and Invasive Lobular Carcinoma (ILC) of the breast on adjuvant tamoxifen.